Target intelligence / Profile preview

KIRREL3 antisense RNA 3 (KIRREL3-AS3)

Target
KIRREL3-AS3
Molecular classification
Other (long non-coding RNA; possibly non-protein coding)
01

Overview

KIRREL3 antisense RNA 3 (KIRREL3-AS3) is classified as a long non-coding RNA (lncRNA), with alternative names including PRR10, NCRNA00288, and Proline-rich protein 10[7][3]. While there are references to putative protein products and catalogued recombinant proteins corresponding to KIRREL3-AS3, the predominant classification across genomic and gene annotation resources is that of a non-protein coding RNA[7][3]. Its precise biological function, molecular activity, and involvement in disease remain uncharacterized, and there is currently no evidence to support its role as a conventional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[7][3][4]. It is distinct from the KIRREL3 gene, which encodes the Kin of IRRE-like protein 3, a well-characterized protein involved in synapse formation and kidney function[1]. The function of KIRREL3-AS3 is not well understood, and there are no documented interacting drugs, mechanism of action, or validated biomarker applications in the current literature or databases[7][3].

Other names
KIRREL3-AS3PRR10NCRNA00288Proline-rich protein 10KIRREL3 antisense RNA 1Putative uncharacterized protein KIRREL3-AS3KIRREL3 antisense gene protein 1KIRREL3 antisense RNA 3 (non-protein coding)proline rich 10FLJ40224
02

Biological functions

Other (unknown/not well characterized)
03

Disease associations

Other (not clearly defined; not a validated disease target)

Beyond the preview

Go deeper on KIRREL3 antisense RNA 3 (KIRREL3-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIRREL3 antisense RNA 3 (KIRREL3-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call